Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
12/06/2011 | CA2345287C Tgf-beta superfamily mutant members, including morphogenic proteins |
12/06/2011 | CA2328783C Human procalcitonin and the preparation and use thereof |
12/06/2011 | CA2328590C Use of a polypeptide derived from a pa1b legume albumen as insecticide |
12/06/2011 | CA2305683C Immunogenic peptides from the hpv e7 protein |
12/06/2011 | CA2304313C Composition and method for enhancing paracellular transport across cell layers |
12/06/2011 | CA2301333C Prb2/p130 peptide inhibitors of cdk2 kinase activity |
12/06/2011 | CA2299609C Universal chloroplast integration and expression vectors, transformed plants and products thereof |
12/06/2011 | CA2232563C Live vaccine carrier strains useful for high level expression of heterologous o-antigens from gram-negative pathogens and derivatives thereof for use as live vaccines |
12/06/2011 | CA2211039C Medicinal combination useful for in vivo exogenic transfection and expression |
12/06/2011 | CA2202087C Cloning and characterizing of genes associated with long-term memory |
12/06/2011 | CA2186573C Sh2-containing inositol-phosphatase |
12/04/2011 | CA2742005A1 Transgenic brassica event mon 88302 and methods of use thereof |
12/02/2011 | CA2741918A1 T-dna/protein nano-complexes for plant transformation |
12/01/2011 | WO2011150342A1 Diffocins and methods of use thereof |
12/01/2011 | WO2011150320A2 Activators of innate immunity |
12/01/2011 | WO2011150168A1 Methods and devices for in situ nucleic acid synthesis |
12/01/2011 | WO2011150117A2 Enhanced disease resistance by introduction of nh3 |
12/01/2011 | WO2011150082A2 Methods of utilizing the arrestin-2/stam-1 complex as a therapeutic target |
12/01/2011 | WO2011150075A2 Compositions and methods for detecting a neoplasia |
12/01/2011 | WO2011150007A2 Treatment of methionine sulfoxide reductase a (msra) related diseases by inhibition of natural antisense transcript to msra |
12/01/2011 | WO2011150005A2 Treatment of atonal homolog 1 (atoh1) related diseases by inhibition of natural antisense transcript to atoh1 |
12/01/2011 | WO2011149852A1 Methods and compositions using listeria for adjuvant treatment of cancer |
12/01/2011 | WO2011149429A1 Use of glycosidases and glycosyltransferases for enhanced protein production |
12/01/2011 | WO2011149354A1 Mirnas involved in the blood brain barrier function |
12/01/2011 | WO2011149310A2 Peptide for inhibiting interaction between rankl and rank, and pharmaceutical composition containing same |
12/01/2011 | WO2011149305A2 Method for detecting mycobacterium tubericulosis and nontuberculous mycobacteria by using dual real-time polymerase chain reaction |
12/01/2011 | WO2011149280A2 Method for detecting mycobacterium tuberculosis and nontuberculous mycobacteria using duplex real-time polymerase chain reaction and melting curve analysis |
12/01/2011 | WO2011149279A2 Method for detecting mycobacterium tuberculosis and nontuberculous mycobacteria using duplex polymerase chain reaction |
12/01/2011 | WO2011149267A2 Primer set for selecting pmmov-resistant pepper varieties, method thereof, and kit thereof |
12/01/2011 | WO2011149255A2 Modified rnase h and detection of nucleic acid amplification |
12/01/2011 | WO2011149248A2 Method for preparing 3-hydroxypropionic acid from glycerol in high yield |
12/01/2011 | WO2011149108A1 Treated cell for accelerating regeneration of biotissue |
12/01/2011 | WO2011149102A1 Highly immunodeficient mouse optimized for bioimaging |
12/01/2011 | WO2011149099A1 Antigen peptide and use thereof |
12/01/2011 | WO2011149057A1 Methods for detection of risk of obesity and risk of onset of diabetes |
12/01/2011 | WO2011148983A1 Induced malignant stem cells or pre-induction cancer stem cells capable of self-replication outside of an organism, production method for same, and practical application for same |
12/01/2011 | WO2011148952A1 Iga-binding peptide and iga purification using same |
12/01/2011 | WO2011148938A1 Protein having diaphorase activity |
12/01/2011 | WO2011148715A1 Normal-tension glaucoma susceptibility gene and method for using the same |
12/01/2011 | WO2011148339A1 A method for producing a polypeptide in yarrowia lipolytica |
12/01/2011 | WO2011148331A1 Means for the transient production in plants of recombinant proteins that can be used in particular in prophylaxis and in therapeutics |
12/01/2011 | WO2011148194A1 Delivery of lentiviral vectors to the brain |
12/01/2011 | WO2011148193A1 Sirna and their use in methods and compositions for the treatment and/or prevention of eye conditions |
12/01/2011 | WO2011148056A1 Process and microorganisms for production of lipids |
12/01/2011 | WO2011148041A1 Modified beta-lactamases and methods and uses related thereto |
12/01/2011 | WO2011148020A1 Polynucleotides and use thereof for obtaining plants resistant to multiple viruses including cucumber vein yellowing virus (cvyv), moroccan watermelon mosaic virus (mwmv), melon necrotic spot virus (mnsv) and zucchini yellow mosaic virus (zymv) |
12/01/2011 | WO2011147995A1 Protein body-inducing polypeptide sequences |
12/01/2011 | WO2011147968A1 Plants with increased fruit size |
12/01/2011 | WO2011147960A1 Antimicrobial peptides and peptide derivatives derived from oncopeltus fasciatus |
12/01/2011 | WO2011147826A1 Method for increasing plant biomass |
12/01/2011 | WO2011147818A2 Production of metabolites |
12/01/2011 | WO2011147622A1 Antigen-presenting modified naïve b cells for immune suppression and a method for producing said modified cells |
12/01/2011 | WO2011147590A2 Tailored recombinase for recombining asymmetric target sites in a plurality of retrovirus strains |
12/01/2011 | WO2011147320A1 B cell activating factor antagonist and preparation method and use thereof |
12/01/2011 | WO2011147319A1 Recombinant human g-csf dimer and use thereof for the treatment of neurological diseases |
12/01/2011 | WO2011147193A1 High-affinity nucleic acid aptamers against sclerostin protein |
12/01/2011 | WO2011147175A1 PREPARATION OF MICROVESICLE-siRNA COMPLEXES AND USE THEREOF IN AIDS TREATMENT |
12/01/2011 | WO2011147138A1 Targeting fusion protein of interleukin and preparation method and use thereof |
12/01/2011 | WO2011147086A1 Microvesicles carrying small interfering rnas, preparation methods and uses thereof |
12/01/2011 | WO2011147057A1 Anti-angiogenic fusion polypeptide, gene and use thereof |
12/01/2011 | WO2011147002A1 Porcine adenovirus 3-based prrsv vaccines |
12/01/2011 | WO2011123489A3 Anti-cd40 antibodies |
12/01/2011 | WO2011121036A3 Induction/ monitoring of arteriogenesis using sdf1 and pdgfb or inhibition of phd2 |
12/01/2011 | WO2011117258A9 Methods of increasing efficiency of vector penetration of target tissue |
12/01/2011 | WO2011114238A3 Shuttle vector based transformation system for pyrococcus furiosus |
12/01/2011 | WO2011112090A3 Method for identifying variant rep protein encoding nucleic acids |
12/01/2011 | WO2011107299A3 Method for the manufacture of recombinant dspa alpha1 |
12/01/2011 | WO2011105901A3 Antagonists of complement component 9 (c9) and uses thereof |
12/01/2011 | WO2011103247A3 Axmi218, axmi219, axmi220, axmi226, axmi227, axmi228, axmi229, axmi230, and axmi231 delta-endotoxin genes and methods for their use |
12/01/2011 | WO2011093606A3 Method and kit for detecting braf mutant using real-time pcr clamping on the basis of pna |
12/01/2011 | WO2011086143A3 Liver targeting domain antibodies |
12/01/2011 | WO2011081501A3 Molecular marker for discrimination of ms3 (nuclear-genetic male sterility gene) and certification method using same |
12/01/2011 | WO2011081415A3 Sirna for inhibiting c-met expression and an anti-cancer composition comprising the same |
12/01/2011 | WO2011066330A3 Selective amplification of polynucleotide sequences |
12/01/2011 | WO2011063921A8 Acceleration of wound healing by a tissue inhibitor of metalloproteinases (timp) linked to glycosylphosphatidylinositol (gpi)-anchors |
12/01/2011 | WO2011061629A3 Yeast strains producing mammalian-like complex n-glycans |
12/01/2011 | WO2011060069A3 Glycosyl transferase from chinese hamster and related methods |
12/01/2011 | WO2011048589A3 Ion exchangers and methods of use thereof |
12/01/2011 | WO2007137114A8 Artificial plant minichromosomes |
12/01/2011 | US20110296558 Polypeptides having expansin Activity and Polynucleotides Encoding Same |
12/01/2011 | US20110296557 Polypeptides Having Lipase Activity And Polynucleotides Encoding Same |
12/01/2011 | US20110296555 Recombinant DNA Constructs and Methods for Modulating Expression of a Target Gene |
12/01/2011 | US20110296554 Specific genetic modification of the activity of trehalose-6-phosphate synthase and expression in a homologous or heterologous environment |
12/01/2011 | US20110296553 Engineering broad and durable resistance to grapevine fanleaf virus in plants |
12/01/2011 | US20110296552 Expression cassettes for seed-specific expression in plants |
12/01/2011 | US20110296551 Plant mitochondria transformation method |
12/01/2011 | US20110296549 Lettuce Cultivar Tenaya |
12/01/2011 | US20110296548 Hybrids of, and Cultivars Derived From the Rice Cultivar Designated 'CL151' |
12/01/2011 | US20110296547 Modifying the dna recombination potential in eukaryotes |
12/01/2011 | US20110296546 Human CTLA-4 Antibodies And Their Uses |
12/01/2011 | US20110296545 Compositions and methods for treating or preventing conditions and diseases associated with mannheimia haemolytica |
12/01/2011 | US20110296541 Production of proteins in eggs |
12/01/2011 | US20110296539 Mutant Alpha-Synuclein, and Methods Using Same |
12/01/2011 | US20110295977 Base sequence cluster generating system, base sequence cluster generating method, program for performing cluster generating method, and computer readable recording medium on which program is recorded and system for providing base sequence information |
12/01/2011 | US20110295023 Dna encoding polypeptide involved in biosynthesis of herboxidiene |
12/01/2011 | US20110294989 Processing of recombinant human g-csf |
12/01/2011 | US20110294984 Glycosylation Engineering of Antibodies for Improving Antibody-Dependent Cellular Cytotoxicity |
12/01/2011 | US20110294983 Single-chain antiparallel coiled coil proteins |
12/01/2011 | US20110294979 Methods for isolating bacteria |
12/01/2011 | US20110294873 Gene Transfer Vectors Comprising At Least One Isolated DNA Molecule Having Insulator Or Boundary Properties And Methods To Identify The Same |